Eric Topol
Eric Topol is a medical researcher whose work focuses heavily on the application and evaluation of artificial intelligence and digital technologies across healthcare. His published research explores clinical AI foundation models, dynamic AI evaluation, robotic surgery, and biological aging clocks. Additionally, he has published studies on multi-cancer early detection, COVID-19 treatments, metabolic mechanisms in neurodegeneration, and appraisals of the wellness industry.
59 claims checked on air: 1 context 1 contradicted 11 overstated 41 supported 5 unverified
What they said on air - unverified
Approximately 20% to 25% of the human population carries the APOE4 allele.
"And if you are APOE4 I mean if you're a carrier that's 20 25% of us are carriers or you have a family history of Alzheimer's or both, you probably want to get a p-tau217" (said at 0:22:33)
No published record matching the claim that approximately 20% to 25% of the human population carries the APOE4 allele was located; this does not prove the claim false.
A randomized clinical study presented at the American Academy of Neurology showed that lifestyle intervention in individuals with elevated p-tau217 reduced p-tau biomarkers by up to 75%.
"And we've seen a randomized study presented here in San Diego at the Academy of Neurology annual meeting where they had these the people who are had p-tau217 elevated they they were randomly assigned to intervention with lifestyle and it came way down you know p-tau217, p-tau181, all these markers 75 up to 75% reduction" (said at 0:23:25)
No published record matching the claim of a randomized clinical study showing a lifestyle intervention reduced p-tau217 or other phosphorylated tau biomarkers by up to 75% was located; this does not prove the claim false. Conference abstracts presented at annual meetings may not yet be published as peer-reviewed articles.
In a 30-day self-experiment consuming ultra-processed food, Chris van Tulleken gained 20 pounds and showed widespread brain inflammation on imaging and elevated inflammatory biomarkers.
"He had a brain scan beforehand. He had all these inflam- inflammation markers beforehand. And in 30 days, kind of like Super Size Me, he tried to go as high as he could on ultra-processed food. By the time the 30 days was up, his brain was all inflamed. Every biomarker had gone through the ceiling of abnormality for inflammation. I mean, it was just 30 days of this bad diet. He gained 20 pounds." (said at 0:31:15)
No published record matching Chris van Tulleken's 30-day ultra-processed food self-experiment, purported 20-pound weight gain, brain inflammation imaging, or elevated inflammatory biomarkers was located; this does not prove the claim false. Although an informal n=1 dietary experiment was conducted for a television documentary and popularized in a non-academic book, no peer-reviewed scientific case report or trial documenting these specific findings exists in the published biomedical literature.
Data from Iceland showed that carrying a BRCA2 mutation was associated with a difference of up to seven years in healthy aging/lifespan, predominantly due to cancer.
"I go through that BRCA2 story in some depth because of the Icelandic data where it made a difference of up to seven years of healthy aging, mainly because of cancer." (said at 1:16:28)
No published record matching the specific claim that Icelandic population data (e.g., from deCODE genetics) demonstrated an association between BRCA2 mutation carriage and up to a 7-year reduction in lifespan or healthy aging predominantly due to cancer was located; this does not prove the claim false.
A full whole-genome sequence can be performed at a cost of a couple hundred dollars.
"they can all be had in a sequence which costs a couple hundred dollars, a full whole-genome sequence." (said at 1:16:28)
No published record matching the claim that a full whole-genome sequence can be performed at a cost of a couple hundred dollars was located; this does not prove the claim false.
Fact-checked episodes
Publications
- Multi-cancer early detection revisited: insights and lessons from the PATHFINDER 2 study.Clinical chemistry and laboratory medicine 2026 · CEBM Level 5
- Critically Appraising the Wellness Movement: Cost Without Value, A Narrative Review.Journal of general internal medicine 2026 · CEBM Level 5
- Trump one year on: How six US researchers plan to protect science amid chaos and cuts.Nature 2026 · CEBM Level 5
- Obesity as a catalyst for neurodegeneration.Nature metabolism 2026 · CEBM Level 5
- Decoding the language of sleep with artificial intelligence.Lancet (London, England) 2026 · CEBM Level 5
- Understanding pre-training data effects in retinal foundation models using two large fundus cohorts.Nature communications 2026 · CEBM Level 3
- A clinical environment simulator for dynamic AI evaluation.Nature medicine 2026 · CEBM Level 5
- Generalist biological artificial intelligence in modeling the language of life.Nature biotechnology 2026 · CEBM Level 5
- Mammography should include artificial intelligence support.Lancet (London, England) 2026 · CEBM Level 5
- Digitising the thymus.Lancet (London, England) 2026 · CEBM Level 5
- COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study.Interactive journal of medical research 2026 · CEBM Level 3
- Large reasoning models as thinking machines for medicine.Nature biomedical engineering 2026 · CEBM Level 5
- Evaluating the robustness and readiness of large frontier models in health AI applications.Nature medicine 2026 · CEBM Level 4
- Biological aging clocks in health and disease.Nature medicine 2026 · CEBM Level 5
- Humanoid robots in the operating room: a framework for staged integration of embodied AI in surgery.NPJ digital medicine 2026 · CEBM Level 5
- Toward a test of medical AI superintelligence.Nature medicine 2026 · CEBM Level 5
- When physicians and AI work together, who is accountable? How to lay out medical liability.Nature 2026 · CEBM Level 5
- From Reactive Care to Predictive Prevention: Harnessing Technology to Transform Cardiovascular Care.Journal of the American College of Cardiology 2026 · CEBM Level 5
- Enabling equitable open access to commercially funded research publications.PLoS medicine 2026 · CEBM Level 5
- A clinical certification pathway for generalist medical AI systems.Lancet (London, England) 2025 · CEBM Level 5
- Advocating for a Master of Digital Health Degree.JAMA 2025 · CEBM Level 5
- Learning the language of life with AI.Science (New York, N.Y.) 2025 · CEBM Level 5
- The rise of agentic AI teammates in medicine.Lancet (London, England) 2025 · CEBM Level 5
- Artificial intelligence for modelling infectious disease epidemics.Nature 2025 · CEBM Level 5
- Is generative artificial intelligence capable of clinical reasoning?Lancet (London, England) 2025 · CEBM Level 5
- Multimodal generative AI for medical image interpretation.Nature 2025 · CEBM Level 5
- Coordinated AI agents for advancing healthcare.Nature biomedical engineering 2025 · CEBM Level 5
- A CRISPR/Cas9-based enhancement of high-throughput single-cell transcriptomics.Nature communications 2025 · CEBM Level 5
- Master of Digital Health Degree-Reply.JAMA 2025 · CEBM Level 5
- Predicting and preventing Alzheimer's disease.Science (New York, N.Y.) 2025 · CEBM Level 5
- A Randomized Trial of At-Home COVID-19 Tests, Telemedicine, and Rapid Prescription Delivery for Immunocompromised Individuals.Mayo Clinic proceedings. Innovations, quality & outcomes 2025 · CEBM Level 2
- Assessing generative artificial intelligence for mental health.Lancet (London, England) 2025 · CEBM Level 5
- A Model for Rapid Innovation for Engagement, Enrollment, and Data and Sample Collection in a Diverse Cohort Study: Insights from All of Us Participant Labs.Mayo Clinic proceedings. Digital health 2025 · CEBM Level 4
- The generative era of medical AI.Cell 2025 · CEBM Level 5
- Beyond Assistance: The Case for Role Separation in AI-Human Radiology Workflows.Radiology 2025 · CEBM Level 5
- Multimodal AI correlates of glucose spikes in people with normal glucose regulation, pre-diabetes and type 2 diabetes.Nature medicine 2025 · CEBM Level 3
- Preserving clinical skills in the age of AI assistance.Lancet (London, England) 2025 · CEBM Level 5
- Catalyzing Health AI by Fixing Payment Systems.NEJM AI 2025 · CEBM Level 5
- Toward the eradication of medical diagnostic errors.Science (New York, N.Y.) 2024 · CEBM Level 5
- AI-Enhanced Reconstruction of the 12-Lead Electrocardiogram via 3-Leads with Accurate Clinical Assessment.medRxiv : the preprint server for health sciences 2024 · CEBM Level 4
- Solving the puzzle of Long Covid.Science (New York, N.Y.) 2024 · CEBM Level 5
- The clinical potential of counterfactual AI models.Lancet (London, England) 2024 · CEBM Level 5
- The hospital at home in the USA: current status and future prospects.NPJ digital medicine 2024 · CEBM Level 5
- Transforming the cardiometabolic disease landscape: Multimodal AI-powered approaches in prevention and management.Cell metabolism 2024 · CEBM Level 5
- Early detection of pancreatic cancer and AI risk partitioning.Lancet (London, England) 2024 · CEBM Level 5
- Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review.The Lancet. Digital health 2024 · CEBM Level 5
- Genome sequence analyses identify novel risk loci for multiple system atrophy.Neuron 2024 · CEBM Level 4
- AI-enabled opportunistic medical scan interpretation.Lancet (London, England) 2024 · CEBM Level 5
- Artificial intelligence in surgery.Nature medicine 2024 · CEBM Level 5
- Medical forecasting.Science (New York, N.Y.) 2024 · CEBM Level 5
- Three-year outcomes of post-acute sequelae of COVID-19.Nature medicine 2024 · CEBM Level 3
- Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review.Journal of the American College of Cardiology 2024 · CEBM Level 5
- Academic Freedom in America - In Support of Institutional Voices.The New England journal of medicine 2024 · CEBM Level 5
- AI-enhanced reconstruction of the 12-lead electrocardiogram via 3-leads with accurate clinical assessment.NPJ digital medicine 2024 · CEBM Level 3
- Digitising the ageing process with epigenetic clocks.Lancet (London, England) 2024 · CEBM Level 5
- Long COVID science, research and policy.Nature medicine 2024 · CEBM Level 5
- The potential for large language models to transform cardiovascular medicine.The Lancet. Digital health 2024 · CEBM Level 5
- Techquity: digital pathways to reach all people for medical research.Lancet (London, England) 2024 · CEBM Level 5
- Generative artificial intelligence and ethical considerations in health care: a scoping review and ethics checklist.The Lancet. Digital health 2024 · CEBM Level 5
- The revolution in high-throughput proteomics and AI.Science (New York, N.Y.) 2024 · CEBM Level 5
- An ethics assessment tool for artificial intelligence implementation in healthcare: CARE-AI.Nature medicine 2024 · CEBM Level 5
- A randomized trial of at-home COVID-19 tests, telemedicine, and rapid prescription delivery for immunocompromised individuals.Research square 2024 · CEBM Level 2
- Long COVID: major findings, mechanisms and recommendations.Nature reviews. Microbiology 2023 · CEBM Level 5
- PRISMA AI reporting guidelines for systematic reviews and meta-analyses on AI in healthcare.Nature medicine 2023 · CEBM Level 5
- Digitising tremor.Lancet (London, England) 2023 · CEBM Level 5
- Foundation models for generalist medical artificial intelligence.Nature 2023 · CEBM Level 5
- Author Correction: Long COVID: major findings, mechanisms and recommendations.Nature reviews. Microbiology 2023 · CEBM Level 5
- Upending the model of AI adoption.Lancet (London, England) 2023 · CEBM Level 5
- The imperative for regulatory oversight of large language models (or generative AI) in healthcare.NPJ digital medicine 2023 · CEBM Level 5
- Rebooting cancer screening with artificial intelligence.Lancet (London, England) 2023 · CEBM Level 5
- Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease.Neurology 2023 · CEBM Level 3
- A foundation model for generalizable disease detection from retinal images.Nature 2023 · CEBM Level 4
- As artificial intelligence goes multimodal, medical applications multiply.Science (New York, N.Y.) 2023 · CEBM Level 5
- The Initial Steps of Multimodal AI in Radiology.Radiology 2023 · CEBM Level 5
- Machines and empathy in medicine.Lancet (London, England) 2023 · CEBM Level 5
- Digitising the outbreak.Lancet (London, England) 2023 · CEBM Level 5
- It's not too late.Science (New York, N.Y.) 2022 · CEBM Level 5
- AI in health and medicine.Nature medicine 2022 · CEBM Level 5
- Bridging the chasm between AI and clinical implementation.Lancet (London, England) 2022 · CEBM Level 5
- Impact of polygenic risk communication: an observational mobile application-based coronary artery disease study.NPJ digital medicine 2022 · CEBM Level 3
- AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK.BMJ open 2022 · CEBM Level 3
- Digitising the prediction and management of sepsis.Lancet (London, England) 2022 · CEBM Level 5
- 6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers.PloS one 2022 · CEBM Level 3
- Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bands.NPJ digital medicine 2022 · CEBM Level 3
- Deep learning a person's risk of sudden cardiac death.Lancet (London, England) 2022 · CEBM Level 5
- Public Misinformation and Science Communication in Times of Public Health Crises.Clinical chemistry 2022 · CEBM Level 5
- Smartphone apps in the COVID-19 pandemic.Nature biotechnology 2022 · CEBM Level 5
- Digitising heart transplant rejection.Lancet (London, England) 2022 · CEBM Level 5
- Operation Nasal Vaccine-Lightning speed to counter COVID-19.Science immunology 2022 · CEBM Level 5
- The digital phenotype of vaccination.Nature biotechnology 2022 · CEBM Level 5
- Self-supervised learning in medicine and healthcare.Nature biomedical engineering 2022 · CEBM Level 5
- Multimodal biomedical AI.Nature medicine 2022 · CEBM Level 5
- Digitising brain age.Lancet (London, England) 2022 · CEBM Level 5
- Sensor-based surveillance for digitising real-time COVID-19 tracking in the USA (DETECT): a multivariable, population-based, modelling study.The Lancet. Digital health 2022 · CEBM Level 3
- The Promise of Digital Health: Then, Now, and the Future.NAM perspectives 2022 · CEBM Level 5
- Variant-proof vaccines - invest now for the next pandemic.Nature 2021 · CEBM Level 5
- Prevalence of Asymptomatic SARS-CoV-2 Infection.Annals of internal medicine 2021 · CEBM Level 5
- What's lurking in your electrocardiogram?Lancet (London, England) 2021 · CEBM Level 5
- Assessing the human immune response to SARS-CoV-2 variants.Nature medicine 2021 · CEBM Level 5
- Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.The New England journal of medicine 2021 · CEBM Level 5
- Messenger RNA vaccines against SARS-CoV-2.Cell 2021 · CEBM Level 5
- AI-facilitated health care requires education of clinicians.Lancet (London, England) 2021 · CEBM Level 5
- The Physiologic Response to COVID-19 Vaccination.medRxiv : the preprint server for health sciences 2021 · CEBM Level 3
- Artificial intelligence, bias, and patients' perspectives.Lancet (London, England) 2021 · CEBM Level 5
- Has SARS-CoV-2 reached peak fitness?Nature medicine 2021 · CEBM Level 5
- Cardiac rehabilitation in the digital era.Lancet (London, England) 2021 · CEBM Level 5
- Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.JAMA network open 2021 · CEBM Level 3
- Radiation oncology 2.0.Lancet (London, England) 2021 · CEBM Level 5
- The Proportion of SARS-CoV-2 Infections That Are Asymptomatic.Annals of internal medicine 2021 · CEBM Level 5
- Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).PloS one 2021 · CEBM Level 2
- Digitising the vision test.Lancet (London, England) 2021 · CEBM Level 5
- From mRNA sensing to vaccines.Immunity 2021 · CEBM Level 5
- Readiness for mammography and artificial intelligence.Lancet (London, England) 2021 · CEBM Level 5
- Passive detection of COVID-19 with wearable sensors and explainable machine learning algorithms.NPJ digital medicine 2021 · CEBM Level 3
- COVID-19 vaccine breakthrough infections.Science (New York, N.Y.) 2021 · CEBM Level 5
- More than meets the eye: Using AI to identify reduced heart function by electrocardiograms.Med (New York, N.Y.) 2021 · CEBM Level 5
- Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation.Heart rhythm O2 2020 · CEBM Level 3